Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause

Completed · Phase 3

Conditions studied: Vaginal Atrophy

In brief

The purpose of this study is to determine whether Bazedoxifine/conjugated estrogens are effective in the treatment of vaginal atrophy.

Key facts

Study ID
NCT00238732
Run by
Wyeth is now a wholly owned subsidiary of Pfizer
People needed
650
Starts
2005-10-01
Expected to finish
2007-03-01
Last updated by the study team
2007-12-28

Who can join

Age: 40 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.